Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • ASAM CONTINUUM Training Videos

    Contains 8 Component(s), Includes Credits

    ASAM CONTINUUM® is a family of products that allows clinicians and non-clinicians to assess patients with addictive, substance-related and co-occurring conditions through computer-guided, structured interviews.

    ASAM CONTINUUM® is a family of products that allows clinicians and non-clinicians to assess patients with addictive, substance-related and co-occurring conditions through computer-guided, structured interviews.

    The six instructional videos offer an overview of the ASAM CONTINUUM® and the CO-Triage® software, explain the computer decision support logic and different components of the assessment, and provide valuable tips for ensuring accurate application of the software. 

    To learn more about the ASAM CONTINUUM tool, please visit www.asamcontinuum.org

    To subscribe for updates regarding ASAM CONTINUUM, please visit https://email.asam.org/h/t/FE9A8EE11FC0D770?


    David Gastfriend

    MD, DFASAM

    David R. Gastfriend, MD, served on the faculty of Harvard Medical School for 25 years, most recently as Director of the Addiction Research Program at Massachusetts General Hospital (MGH). His studies of the Patient Placement Criteria published by the American Society of Addiction Medicine (ASAM) have been supported by the NIH's National Institute on Drug Abuse, the National Institute on Alcohol Abuse and Alcoholism, the U.S. Centers for Disease Control, U.S. state governments, managed care corporations, including Aetna Behavioral Healthcare, and foreign governments, including Belgium, Finland, Iceland, Israel, Norway, Switzerland, and the World Health Organization. The author of over 125 scientific publications, he has served on the Boards and Editorial Boards of a number of societies and journals, including ASAM and the International Society of Addiction Medicine (ISAM). He is co-editor of the leading book on treatment matching in the field, The ASAM Patient Placement Criteria for Substance-Related Disorders and editor of Addiction Treatment Matching. In addition to his role at RecoverySearch, Dr. Gastfriend is also Vice President for Scientific Communications at Alkermes, Inc. (NASDAQ: ALKS) where he is involved in research, education and scientific publication on extended-release naltrexone (VIVITROL®) and the company's efforts in the field of addiction treatment.

  • Webinar - The Addiction Medicine Exam & ASAM Resources You Need

    Contains 1 Component(s)

    This recorded webinar provides an overview of the key eligibility requirements to become certified in addiction through the American Board of Preventive Medicine (ABPM) and explores the pathways to gain initial certification. It will then move on to the importance of preparing for the ABPM Addiction Medicine Exam and highlight ASAM board exam resources to better assist in your preparation.

    Original Recording Information

    Date:   Wednesday, June 12, 2019

    Time:   11:30 am ET/10:30 am CT/8:30 am PT

    Speaker:   Michael Weaver, MD, DFASAM

    Moderator:   Amanda Weber, Senior Manager, Professional Development, ASAM

    Objectives

    •Understand the key eligibility requirements & certification pathways to become a certified addiction specialist
    •Understand how to apply for the ABPM addiction medicine exam
    •Understand the ASAM resources available to help you  prepare for the exam and maintain certification

    Michael Weaver

    MD, DFASAM

    Michael Weaver, MD, DFASAM is a Professor in the Department of Psychiatry and Medical Director of the Center for Neurobehavioral Research on Addictions (CNRA) at the McGovern Medical School at the University of Texas Health Science Center at Houston (UTHealth). He received his M.D. degree from Northeast Ohio Medical University, and completed Residency in Internal Medicine and a Clinical Research Fellowship in Addiction Medicine at Virginia Commonwealth University (VCU) Health System, and he is Board-certified in Internal Medicine through the American Board of Internal Medicine and certified in Addiction Medicine through the American Board of Preventive Medicine. Dr. Weaver is the Sub-Board Chair for Addiction Medicine on the American Board of Preventive Medicine, and also serves as the Chair of the Examination Committee for certification in Addiction Medicine. He has been a member of ASAM for over 20 years and currently serves as a member of the Publications Council and the Annual Conference Program Planning Committee. He is currently involved in patient care, medical education, and research. Dr. Weaver sees patients in the Innovations Addiction Treatment Clinic at the Texas Medical Center in Houston. He has extensive experience teaching about addiction to medical students, residents, and community professionals at all levels. He has been involved in multiple research projects, and currently is collaborating with other researchers in the CNRA on studies involving cocaine, methamphetamine, marijuana, and electronic cigarettes. Dr. Weaver has multiple publications in the field of addiction medicine, including the book "Addiction Treatment" published by Carlat Publishing in 2017.

  • Board Exam Study Tool (BEST) - 2019 (17 CME)

    Contains 5 Component(s), Includes Credits

    Earn a maximum of 17 CME while learning from the BEST. This study tool helps prepare physicians for the ABPM certification/re-certification examination utilizing an interactive and engaging format.

    image


    The ASAM Board Examination Study Tool (BEST) helps prepare physicians for the ABPM certification/re-certification examination utilizing an interactive and engaging format.*


    *Note: Live attendees of the 2019 ASAM Review Course in Addiction Medicine in Dallas, TX can opt to receive the 2019 BEST at a reduced price of $100 if they sign up for the BEST on-site. Register for the Review Course Now!


    The NEW 2019 BEST Includes:


    700 Board-Style Self-Assessment Questions
    • Developed, reviewed and mapped to the ABPM exam blueprint content areas by national experts
    • Flexible learning modes allow users to design their study sessions and focus on specific topics
    • Personalized Reporting 
    • Access personal performance analysis reports and create a personalized study guide based on responses to the question bank
    Excerpts and Highlights 
    • High-level summaries from select chapters from the newly released Principles of Addiction Medicine, Sixth Edition
    Glossary
    • Explore a list of important terms and definitions in the addiction medicine field
    Additional Resources
    • Review the presentations slides from the 2019 ASAM Review Course in Addiction Medicine
    • View a list of additional resources recommended by Review Course faculty by topic


    Registrants will have access to content and be able to claim CME for one year from the date they start the tool. 



    Additional Board Exam Preparation resources and tools are also available.

    Goals and Objectives

    Upon completion of this education activity, participant should be able to:

    • Differentiate between important terms and definitions in the field of Addiction Medicine.
    • Distill knowledge on key points from the text, the Principles of Addiction Medicine, 6th edition and course slides
    • Appraise addiction patient cases and respond accurately to questions about next steps and treatment options.
    • Employ knowledge gained in the educational sections of the BEST to respond accurately to self-assessment questions.

    Participants of the 2019 ASAM Review Course in Addiction Medicine and other physicians who are preparing for the ABPM Certification Exam in Addiction Medicine.

    NameCommercial InterestsCompensation ReceivedRole
    Timothy Brennan MD, MPH, FASAMNoneNANA
    Jeffrey DeVido MDAltria/Philip MorrisStockInheritance
    Paul Earley MD, DFASAMAlkermes, Inc; DynamiCare Health, IncHonoraria; SalarySpeaker; VP of Medical Affairs
    James Finch MD, DFASAMNoneNANA
    Marc Fishman MD, DFASAMUS World Meds; AlkermesConsulting fee, Travel; HonorariaConsultant; Advisory Board
    David Galbis-Reig MD, DFASAMAscension Wisconsin All Saints; Abbvie; Hospira; RespireRX Pharmaceuticals; Abbott Pharmaceuticals; Pfizer BondStock & Bond in Retirement IRA; Stock Options; Ownership InterestsOwner; Advisory Board; PI; Consultant
    R. Jeffrey Goldsmith, MD, DLFAPA, DFASAMNoneNANA
    Adam Gordon, MD, MPHNoneNANA
    Leslie Hayes, MDNoneNANA
    Abigail Herron DO, DFASAMNoneNANA
    Petros Levounis MD, MA, FASAMNoneNANA
    Carla Marienfeld MDNoneNANA
    Ricardo Restrepo MD, MPH, FASAMNoneNANA
    Richard Ries MD, DFASAMNoneNANA
    Edwin Salsitz MD, DFASAMNoneNANA
    Sharon Stancliff MD, FASAMNoneNANA
    Timothy Wiegand MD, FACMT, FAACTNoneNANA
    Erin Zerbo, MDNoneNANA
    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring material for a maximum of 17 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 17 LLSA credits towards ABPM MOC Part II requirements.

    ABAM Transitional Maintenance of Certification (tMOC)

    This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of 17 AMA PRA Category 1 Credit(s)™ for completing this course.

  • Impact of Nicotine and Other Stimulants on Sleep in Young Adults (1 CME)

    Contains 4 Component(s), Includes Credits

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning about the impact of stimulants on sleep in young adults from The Journal of Addiction Medicine 2019.

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning about the impact of stimulants on sleep in young adults in this journal article from The Journal of Addiction Medicine 2019. Michael D. Stein, MD, Celeste M. Caviness, PhD and Bradley J. Anderson, PhD


    Learning objectives: 

    1.) Explore the relationship of commonly used stimulant substances to poor sleep in quality in young adults

    2.) Assess the varying impact of different stimulants on sleep 

  • Recovery Goals and Long-term Treatment Preference in Persons Who Engage in Nonmedical Opioid Use (1 CME)

    Contains 4 Component(s), Includes Credits

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning about recovery and treatment with nonmedical opioid use from The Journal of Addiction Medicine 2019.

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning about the recovery and treatment with nonmedical opioid use in this journal article from The Journal of Addiction Medicine 2019. Andrew S. Huhn, PhD, MBA, Kaitlyn R. Hay, MS, David Andrew Tompkins, MD, MHS, Kelley E. Dunn, PhD


    Learning objectives: 

    1.)  Identify recovery goals and treatment preferences to maximize treatment initiation and retention 

    2.)  Explain the proportion of out of treatment individuals with non-medical opioid use that have abstinent and non-abstinent recovery goals

    3.) Understand how patients can be matched to treatments, which can help promote early treatment satisfaction and retention


  • Opioid and Cannabis Co-Use among Adults with Chronic Pain: Relations to Substance Misuse, Mental Health, and Pain Experience(1 CME)

    Contains 4 Component(s), Includes Credits

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning about opioid and cannabis co-use among adults with chronic pain The Journal of Addiction Medicine 2019.

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning about learning about opioid and cannabis co-use among adults with chronic pain in this journal article from The Journal of Addiction Medicine 2019. Andrew S. Huhn, PhD, MBA, Kaitlyn R. Hay, MS, David Andrew Tompkins, MD, MHS, Kelley E. Dunn, PhD


    Learning objectives: 

    1.)  Identify how the co-use of substances is generally associated with poorer outcomes than single substance use

    2.)  Understand how opioid and cannabis co-use is associated with higher anxiety and depression symptoms 



  • Depressive Symptoms and Suicidality in Adolescents Using e-Cigarettes and Marijuana: A Secondary Data Analysis From the Youth Risk Behavior Survey (1 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning about depressive symptoms and suicidality in adolescents using e-cigarettes and marijuana from The Journal of Addiction Medicine 2019.

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning about learning about depressive symptoms and suicidality in adolescents using e-cigarettes and marijuana The Journal of Addiction Medicine 2019. Nicholas Chadi, MD, Guilin Li, MBBS, Natalie Cerda, MD, and Elissa R. Weitzman, ScD, MSc


    Learning objectives: 

    1. Summarize recent trends in rates of adolescent e-cigarette and marijuana use

    2. Name the two main psychoactive substances found in e-cigarettes and marijuana

    3. Discuss the association between single and dual use of e-cigarettes and marijuana use and depressive and suicidal symptoms among high school students



  • Medical Burden of Disease Among Individuals in Recovery from Alcohol and Other Drug Problems in the United States: Findings from the National Recovery Survey (1 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning about the medical burden of disease among individuals in recovery from The Journal of Addiction Medicine 2019.

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning about the medical burden of disease among individuals in recovery from The Journal of Addiction Medicine 2019. David Eddie, PhD, M. Claire Greene, PhD, MPH, William L. White, MA, and John F. Kelly, PhD


    Learning objectives: 

    1. Describe the prevalence of medical sequelae of substance use disorder among individuals in recovery from alcohol and other drug problem

    2. Relate these prevalence rates to the general Unites States population

    3. Discuss the relationship between disease and quality of life in this population



  • Screening, Brief Intervention, and Referral to Treatment in a Retail Pharmacy Setting: The Pharmacist’s Role in Identifying and Addressing Risk of Substance Use Disorder (1 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning about the pharmacist's role in identifying and dressing risks of SUD from The Journal of Addiction Medicine 2019.

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning about the the pharmacist's role in identifying and dressing risks of SUD from The Journal of Addiction Medicine 2019. Richard M. Gustin, PhD, Brian C. Shonesy, PhD, Donald Williams, BS, Damian Simmons, PharmD, Erin Dorval, PharmD and Stuart Gitlow, MD, MPH, MBA, 


    Learning objectives: 

    1. Describe how to facilitate Screening, Brief Intervention and Referral to Treatment (SBIRT) in a community pharmacy setting

    2. Explain the importance of using the prescription drug monitoring program (PDMP).

    3. Discuss the importance of integrating the pharmacy/pharmacist into substance use disorder identification and collaboration with treatment.



  • Webinar: The ASAM Criteria Copyright and Permissions Process for States

    Contains 1 Component(s)

    In this free webinar, learn about the ASAM Criteria copyright and permissions process for states.

    Webinar Overview

    In Spring 2019, The ASAM Criteria copyright and permissions process was updated to include agreements to enable public entities, providers, and other stakeholders to reference their use of The ASAM Criteria. The changes are part of a range of programs designed to support effective implementation of The ASAM Criteria and protect ASAM’s intellectual property from misuse. These programs include an ASAM Level of Care certification program delivered by CARF, a robust training program on The ASAM Criteria, and ongoing enhancements to the ASAM CONTINUUM software – a clinical decision support tool used to assist in treatment planning for individuals with addiction. All of these initiatives have the end goals of protecting patients and preserving the credibility of providers accurately implementing the evidence-based standards found in The ASAM Criteria.

    Margaret A.E. Jarvis

    MD, DFASAM

    Margaret Jarvis finished her medical school, psychiatry residency and Addiction Medicine Fellowship at the Medical College of Virginia in Richmond. She is board certified and recertified in psychiatry with the CAQ in Addiction Psychiatry. She was ASAM certified (now ABAM certified). She has been a member of ASAM since the early 90’s and became a Fellow of the Society in 2003. She has served on the Board of Directors for one term and currently is the co-chair of the Ruth Fox Planning; and a member of the Finance Committee and the Constitution and Bylaws Committee. She has also worked on Examination Committee for ASAM and now ABAM since 2000.

    Dr. Jarvis is the Medical Director at Marworth, in Waverly, PA, which is the residential addiction treatment center for the Geisinger Health System. She has been in this position since 1999. She is also Clinical Assistant Professor of Psychiatry at the Penn State University College of Medicine in Hershey, PA.

    Dr. Jarvis is a member of the Society for the Advancement of Sexual Health, a professional organization of therapists who treat sexual addiction, and served on that board of directors from 2001-2006, as president from 2004-2006. She received the Merit award from SASH in 2011. Dr. Jarvis currently serves as the Treasurer of the Board of Marley’s Mission, a non-profit that provides equine-assisted psychotherapy to abused children in the Scranton, PA area.